Clinical Trials Directory

Trials / Unknown

UnknownNCT06324500

Prognostic Role of Bowel Ultrasound Scan in Children Affected by Acute Severe Colitis

Prognostic Role of Bowel Ultrasound Scan in Children Affected by Acute Severe Colitis (ASC): A Prospective Multicenter Study From the Paediatric IBD Porto Group of ESPGHAN

Status
Unknown
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
Meyer Children's Hospital IRCCS · Academic / Other
Sex
All
Age
1 Year – 17 Years
Healthy volunteers
Not accepted

Summary

ASC is a life-threatening medical emergency. The lack of a timely intervention has shown to be associated with a mortality rate higher than 20% in adults, whereas a prompt targeted therapy has displayed a decrease of the aforementioned rate to 1%. Therefore, the identification of predictors of poor outcome trough an objective tool may provide crucial help to individualize the timing of second line treatment initiation. At the state of the art, PUCAI represents the only validated tool to appraise the risk of first-line treatment failure and there is a lack of objective methods with a prognostic value in ASC. BUS has proven to be a reliable tool in assessing disease activity in children with UC and it has also shown statistically significant correlation with endoscopic features of disease activity. Given the literature suggesting a role for BUS in severe UC and the results from our retrospective study we aim to validate our findings trough a prospective assessment of the potential prognostic role of BUS in ASC.

Conditions

Timeline

Start date
2020-03-02
Primary completion
2025-03-02
Completion
2025-05-02
First posted
2024-03-22
Last updated
2024-03-22

Locations

4 sites across 2 countries: Italy, Spain

Source: ClinicalTrials.gov record NCT06324500. Inclusion in this directory is not an endorsement.